AYTU
Aytu BioPharma, Inc.
2.17
1 x 1.56
2 x 2.82
bid
ask
+
0.02
0.72%
10:12 AM
timesize
| Ytd | -16.52% | |
| 1y | -5.22% |
2.17
day range
2.20
1.65
52 week range
3.07
| Open | 2.20 | Prev Close | 2.15 | Low | 2.17 | High | 2.20 | Mkt Cap | 23.30M |
| Vol | 492.00 | Avg Vol | 38.37K | EPS | -4.61 | P/E | N/A | Forward P/E | 3.57 |
| Beta | -1.40 | Short Ratio | 10.45 | Inst. Own | 34.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 2.29 | 200-d Avg | 2.37 | 1yr Est | 8.00 |
| Income Statement | |||
| Total Revenue | 12.41M | ||
| Revenues (USD) | 12.41M | ||
| Cost of Revenue | 4.81M | ||
| Gross Profit | 7.60M | ||
| Operating Expenses | 11.66M | ||
| Selling, General and Administrative Expense | 10.90M | ||
| Operating Income | -4.06M | ||
| Interest Expense | 436.00K | ||
| Income Tax Expense | 10.00K | ||
| Net Income | -5.62M | ||
| Net Income Common Stock | -5.62M | ||
| Net Income Common Stock (USD) | -5.62M | ||
| Consolidated Income | -5.62M | ||
| Earnings per Basic Share | -0.53 | ||
| Earnings per Basic Share (USD) | -0.53 | ||
| Earnings per Diluted Share | -0.53 | ||
| Earning Before Interest & Taxes (EBIT) | -5.17M | ||
| Earning Before Interest & Taxes (USD) | -5.17M | ||
| Weighted Average Shares | 10.51M | ||
| Weighted Average Shares Diluted | 10.51M | ||
| Balance Sheet | |||
| Cash and Equivalents | 26.72M | ||
| Cash and Equivalents (USD) | 26.72M | ||
| Trade and Non-Trade Receivables | 24.49M | ||
| Current Assets | 67.33M | ||
| Property, Plant & Equipment Net | 1.32M | ||
| Total Assets | 111.69M | ||
| Debt Current | 12.27M | ||
| Total Debt | 21.82M | ||
| Current Liabilities | 59.97M | ||
| Debt Non-Current | 9.55M | ||
| Total Liabilities | 76.55M | ||
| Accumulated Retained Earnings (Deficit) | -347.77M | ||
| Shareholders Equity | 35.14M | ||
| Shareholders Equity (USD) | 35.14M | ||
| Assets Non-Current | 44.36M | ||
| Total Debt (USD) | 21.82M | ||
| Goodwill and Intangible Assets | 42.49M | ||
| Inventory | 7.46M | ||
| Liabilities Non-Current | 16.57M | ||
| Trade and Non-Trade Payables | 13.21M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.12M | ||
| Net Cash Flow from Financing | 872.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.31M | ||
| Issuance (Repayment) of Debt Securities | 872.00K | ||
| Net Cash Flow from Operations | -4.18M | ||
| Share Based Compensation | 148.00K | ||